logo
Share SHARE
FONT-SIZE Plus   Neg

New York Community Bancorp Q1 Profit Down - Quick Facts

New York Community Bancorp Inc. (NYB) reported that its first-quarter GAAP earnings were $118.3 million, or $0.27 per share, down from $123.2 million, or $0.28 per share in the year ago quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $0.26 per share. Analysts' estimates typically exclude special items.

Operating earnings totaled $117.8 million or $0.27 per share, compared to $117.2 million or $0.27 per share in the year ago quarter.

Net interest income for the quarter declined to $288.41 million from $303.25 million in the prior year quarter. Total non-interest income was $61.99 million, up from $58.61 million in year ago quarter.

The company said that its board declared quarterly cash dividend of $0.25 per share. The dividend is payable on May 17th to shareholders of record at the close of business on May 7, 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of International Consolidated Airlines Group S.A. were gaining around 3 percent in London trading after the airline reported Friday higher profit in its second quarter, benefited by higher passenger revenues, despite weak cargo revenues. The company now expects low double digit percentage growth in pre-exceptional operating profit in 2016. Swiss banking giant UBS Group AG reported Friday a 14 percent decline in second quarter profit with weakness in net interest income. Looking ahead, the company said the difficult conditions continue to persist, yet the firm is well positioned to benefit from even a moderate improvement in conditions. UBS shares were gaining around 3 percent in the morning trading in Zurich. We are well into the third quarter and past the middle of the year and it is time to take stock of regulatory decisions awaiting some biotech stocks in August. Despite the uncertain macroeconomic environment, the markets have run up, with the S&P 500 Index making new highs session after session. Valuation concerns may keep traders at bay. However, the biotech space is a different cup of tea.
comments powered by Disqus
Follow RTT